S&P 500 Tests Breakout as Dow and Nasdaq Hold Key Support
The NASDAQ 100 has been a bit noisy in pre-market trading and overnight electronic trading on Monday, as we continue to hang around the 50-day EMA. Currently, it looks as if the market is trying to determine whether this has been a bit of a pullback or if it becomes something a little bit more substantial.
» Read more about: S&P 500 Tests Breakout as Dow and Nasdaq Hold Key Support »
Read MoreHow Nvidia stacks up against major chip peers ahead of earnings
BING-JHEN HONG/iStock Editorial via Getty Images
Nvidia (NVDA) heads into its Aug. 26 earnings report with the AI-chip leader trailing several major semiconductor peers in 2026, putting added focus on whether its results and outlook can reignite investor enthusiasm.
» Read more about: How Nvidia stacks up against major chip peers ahead of earnings »
Read More3 Things Nvidia Needs to Get Right This Week
If you think Nvidia (NVDA -1.42%) has been a volatile stock in recent weeks, you might want to buckle your seat belts. The artificial intelligence (AI) bellwether will report its fiscal second-quarter results after the market close on Wednesday afternoon.
Nvidia shares will be on the move.
» Read more about: 3 Things Nvidia Needs to Get Right This Week »
Read MoreStock market today: S&P 500, Nasdaq slip as tech stocks sag, US-Canada talks break down
US stocks mostly slipped ahead of an action-packed week featuring Nvidia (NVDA) earnings and the Federal Reserve’s Jackson Hole Symposium. The Trump administration is also expected to announce the details of new economic sanctions against Iran.
The S&P 500 (^GSPC) declined by 0.4%,
Read MoreNew Fed chair Kevin Warsh under pressure to clarify views on inflation, interest rates
WASHINGTON (AP) — New Federal Reserve chair Kevin Warsh has brought sharp change in how the central bank communicates by saying much less than his predecessors about the economy and inflation.
But so far, many economists and Wall Street investors haven’t been thrilled with that approach.
On Friday, Warsh has a high-stakes opportunity to address those concerns and underscore his inflation-fighting bona fides when he gives his speech in Jackson Hole,
Read MoreThe Burst
120,000 Reasons to Buy This Wide Moat Stock
Toast (NYSE:TOST) is a cloud technology provider that specializes in restaurant point-of-sale systems. The company’s software allows restaurants to process sales, track and manage inventories and even manage payroll and HR functions. To use these tools, restaurants purchase Toast’s POS, giving the company an effective competitive moat in every restaurant that decides to use it.
» Read more about: 120,000 Reasons to Buy This Wide Moat Stock »
Read MoreThe Ivy
Has Medical Properties Trust Bottomed Out? The Case for a Comeback
Medical Properties Trust (NYSE:MPW) is a REIT that focuses on hospitals and other medical facilities. The company has been through an extremely trying couple of years, resulting in both dividend cuts and deteriorating share prices.
Now, however, things seem to finally be improving at Medical Properties Trust. Is MPW a buy as the business turns itself around,
» Read more about: Has Medical Properties Trust Bottomed Out? The Case for a Comeback »
Read MoreThe Spotlight
Spotlight: 1 Gene Editing Stock Set To Skyrocket
Cathie Wood has been investing heavily in Verve Therapeutics (VERV), a company developing therapies for cardiovascular diseases. So what’s all the fuss about? We took a deeper dive to find out.